These results were consistent across all clinically relevant patient subgroups regardless of key patient characteristics like age or sex, the cause of stroke or the severity of the stroke
A PRV is a tradable voucher granted by the FDA to encourage the development of new treatments for rare pediatric diseases
The early-stage trial demonstrated an excellent safety profile alongside clinically meaningful improvements in visual acuity
UNLOXCYT is an evolution in checkpoint inhibition and is now available for the treatment of adults in the U.S. with mCSCC or laCSCC who are not candidates for curative surgery or curative radiation
Experts caution that realizing AI’s potential requires careful management and risk mitigation
This product has only one approved generic and one authorized generic with an addressable market share of US$ 172 million
Kelun-Biotech and Crescent Biopharma forged a collaboration covering SKB105/CR-003 and SKB118, a PD-1 x VEGF bispecific antibody also known as CR-001
Tolebrutinib had been provisionally approved in the United Arab Emirates in July 2025 for nrSPMS to slow disability accumulation independent of relapse activity
Tablets will be manufactured at Granules' US-based facility located in Chantilly, Virginia
Efdoralprin alfa, a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein, showed superior efficacy to standard plasma-derived therapy in adults with AATD
Subscribe To Our Newsletter & Stay Updated
